1991
DOI: 10.1111/j.1365-2958.1991.tb00757.x
|View full text |Cite
|
Sign up to set email alerts
|

The IgA‐binding β antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions

Abstract: The beta antigen of the lbc protein complex of Group B streptococci is a cell-surface receptor which binds the Fc region of human immunoglobulin A (IgA). Determination of the nucleotide sequence of the beta antigen gene shows that it encodes a preprotein having a molecular weight of 130,963 daltons and a polypeptide of 1164 amino acid residues that is typical of other Gram-positive cell-wall proteins. There is a long signal sequence of 37 amino acids at the N-terminus. Four of the five C-terminal amino acid re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
98
0

Year Published

1992
1992
2010
2010

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 109 publications
(100 citation statements)
references
References 26 publications
2
98
0
Order By: Relevance
“…At the N-terminal end of the protein, there is a potential signal-peptidase cleavage site (von Heijne, 1986) at amino acid 37. The predicted signal sequence of SpsA shows features common to other leader sequences of Gram-positive bacteria and is, for example, highly homologous to the signal sequence of ␤-antigen of c-protein of group B streptococci (Jerlströ m et al, 1991). Comparison of the signal sequences revealed an identity of 75% and 92% similarity, when conservative amino acid substitutions are taken into account.…”
Section: Features Of Spsa Protein and Homologies With Other Proteinsmentioning
confidence: 83%
See 1 more Smart Citation
“…At the N-terminal end of the protein, there is a potential signal-peptidase cleavage site (von Heijne, 1986) at amino acid 37. The predicted signal sequence of SpsA shows features common to other leader sequences of Gram-positive bacteria and is, for example, highly homologous to the signal sequence of ␤-antigen of c-protein of group B streptococci (Jerlströ m et al, 1991). Comparison of the signal sequences revealed an identity of 75% and 92% similarity, when conservative amino acid substitutions are taken into account.…”
Section: Features Of Spsa Protein and Homologies With Other Proteinsmentioning
confidence: 83%
“…The N-terminal part of SpsA with the SC-binding domain exhibits no homology either to pneumococcal IgA1-protease (Poulsen et al, 1996) or to other pneumococcal proteins (Paton et al, 1993). It also showed no homology to IgA-binding proteins from other bacterial species (Lindahl and Ä kerströ m, 1989;Jerlströ m et al, 1991). The purified SIgA-binding domain (amino acids 38-324) could, in low concentrations, completely inhibit competitively the binding of SIgA to pneumococci.…”
Section: Discussionmentioning
confidence: 99%
“…agalactiae is an important human pathogen. S. agalactiae is a B group Streptococcus that causes meningitis in newborns (Jerlstrom et al, 1991). The IgA Fc receptor is part of the c complex that may contribute to the virulence of this organism (Lancefield et al, 1975).…”
mentioning
confidence: 99%
“…The IgA Fc receptor is part of the c complex that may contribute to the virulence of this organism (Lancefield et al, 1975). Two specific IgA-binding regions have been defined; the second of these two regions contains the Ig-like domain (Jerlstrom et al, 1991). It is noteworthy that the human IgA Fc receptor contains two immunoglobulin-like domains.…”
mentioning
confidence: 99%
“…The non-repeated N-terminal region of R28 includes a region (shaded), which does not fit into the alignment with Rib. This region can be divided into two subregions, one with homology to the repeat region of the GBS α protein, which belongs to the same family as Rib and R28 [24], and one with homology to the GBS β protein, which is unrelated to the Rib and α proteins [45,46]. Thus, the R28 protein can be viewed as a chimera derived from three different GBS proteins [24].…”
Section: Vaccine Development: a Problem With Animal Modelsmentioning
confidence: 99%